231
THE VACCINE Johnson & Johnson passed the EMA exam that gave the green light in Europe to the immunization that had been stopped in mid-April in the United States. The overall benefit-risk ratio “remains positive”. The Safety Committee (Prac) of the EMA reports that the “very rare cases of unusual blood clots with low platelets” that have occurred in the US may have a link with the administration of the Covid-19 Janssen vaccine.
.